Cargando…

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis

Introduction: Patients with systemic AL amyloidosis (AL) should be evaluated for cardiac amyloidosis (CA), as prognosis is strongly related to cardiac involvement. We assessed the characteristics of patients referred to cardiac magnetic resonance (CMR) with suspected CA from a cancer center and dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agha, Ali M., Palaskas, Nicolas, Patel, Amit R., DeCara, Jeanne, Parwani, Purvi, Iliescu, Cezar, Durand, Jean B., Kim, Peter, Hassan, Saamir, Gladish, Gregory, Lee, Hans C., Kaufman, Gregory P., Lopez-Mattei, Juan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276072/ https://www.ncbi.nlm.nih.gov/pubmed/34268341 http://dx.doi.org/10.3389/fcvm.2021.626414

Ejemplares similares

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018)

Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy
por: Heidari-Bateni, Giv, et al.
Publicado: (2021)

Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis
por: Koutroumpakis, Efstratios, et al.
Publicado: (2023)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Multimodality imaging in carcinoid heart disease
por: Agha, Ali M, et al.
Publicado: (2019)

Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography
por: Agha, Ali M., et al.
Publicado: (2020)

Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
por: Zarifa, Abdulrazzak, et al.
Publicado: (2021)

Fulminant cardiac amyloidosis
por: Real, Carlos, et al.
Publicado: (2021)

Cardiac sarcoidosis mimics cardiac amyloidosis in an elderly patient
por: Kafil, Tahir S, et al.
Publicado: (2022)

Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis
por: Ahmed, Talha, et al.
Publicado: (2022)

Trigger related outcomes of takotsubo syndrome in a cancer population
por: Safdar, Ayesha, et al.
Publicado: (2022)

Rate of Progression of Aortic Stenosis in Patients With Cancer
por: Bravo-Jaimes, Katia, et al.
Publicado: (2021)

Skip Soft Definitions and Focus on Hard Endpoints
por: Lopez-Mattei, Juan C., et al.
Publicado: (2019)

Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients
por: Monlezun, Dominique J., et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
por: Palaskas, Nicolas, et al.
Publicado: (2020)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Spontaneous intramyocardial haematoma in transthyretin cardiac amyloidosis
por: Parizher, Gary, et al.
Publicado: (2022)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging
por: Chamling, Bishwas, et al.
Publicado: (2021)

Cardiac Amyloidosis: A Review of Current Imaging Techniques
por: Razvi, Yousuf, et al.
Publicado: (2021)

How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
por: Jacob, Robin, et al.
Publicado: (2021)

Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis
por: Kim, Jin Young, et al.
Publicado: (2021)

Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis
por: Banydeen, Rishika, et al.
Publicado: (2022)

The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update
por: Khanna, Shaun, et al.
Publicado: (2020)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia
por: Wilson, Nathaniel R., et al.
Publicado: (2021)

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis
por: Sperry, Brett W., et al.
Publicado: (2021)

Diagnostic Value of (11)C-PIB PET/MR in Cardiac Amyloidosis
por: Bi, Xiao, et al.
Publicado: (2022)

Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging
por: Guo, Xinli, et al.
Publicado: (2021)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
por: Abramov, Dmitry, et al.
Publicado: (2021)

Myocardial Biopsy in a History of Light-Chain Amyloidosis Patient With Serial Cardiac Magnetic Resonance Imaging Not Suggestive of Cardiac Involvement
por: Mizutani, Hana, et al.
Publicado: (2019)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis
por: Wu, Yan, et al.
Publicado: (2022)

Diagnosis of Cardiac Amyloidosis Using a Radiomics Approach Applied to Late Gadolinium-Enhanced Cardiac Magnetic Resonance Images: A Retrospective, Multicohort, Diagnostic Study
por: Zhou, Xi Yang, et al.
Publicado: (2022)

Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
por: Wang, Jinghua, et al.
Publicado: (2022)

Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease
por: Raval, Maharshi, et al.
Publicado: (2022)

Screening approaches to cardiac amyloidosis in different clinical settings: Current practice and future perspectives
por: Caponetti, Angelo Giuseppe, et al.
Publicado: (2023)

Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patient
por: Mróz, Krystian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vka7se5n4ha2kqnbtv21cmmttg